21.10.2010 - EU antitrust regulators plan to review drug patent settlements struck this year to delay cheaper generics going to market, as part of their crackdown on illegal deals, a senior...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)